 Crossmark Global Holdings Inc. raised its holdings in Charles River Laboratories Intl. Inc NYSE:CRL by 5.6 in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 18,345 shares of the medical research companys stock after acquiring an additional 977 shares during the period. ... 